Diabetes technology

Psychometric Properties of the Automated Insulin Delivery: Benefits and Burdens Scale for Adults with Type 1 Diabetes

Diabetes Technol TherPublished Psychometric validation study

Authors' conclusion

Findings support the AID-BBS as a psychometrically valid, reliable, and useful instrument for assessing burdens and benefits associated with AID system use in adults with T1D.

Study context

Population
Adults with T1D (ages 18 to 82 years) enrolled in an AID system research trial
Participants
217 adults
Outcome
Psychometric properties of the Automated Insulin Delivery-Benefits and Burdens Scale (AID-BBS)
Follow-up
6 and 13 weeks
Methodological detailswithin an AID system research trial
  • Within an AID system research trial

Performance

As reported in the abstract

  • Exploratory factor analysis supported a one-factor structure for each subscale (15-item benefit, 9-item burden) when evaluated separately
  • Convergent, discriminant and predictive validity, internal consistency and test-retest reliability were supported
  • Benefit and burden subscales at week 6 predicted usage intention beyond device impact on glycemic outcomes, controlling for baseline glycemic outcomes

Original publication

Psychometric Properties of the Automated Insulin Delivery: Benefits and Burdens Scale for Adults with Type 1 Diabetes. Diabetes Technol Ther. Published 31 May 2024. doi:10.1089/dia.2024.0117

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.